Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine

Benjamin Young, Kathleen E. Squires, Karen Tashima, Keith Henry, Stefan Schneider, Anthony LaMarca, Henry H. Zhao, Lisa L. Ross, Mark S. Shaefer

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine'. Together they form a unique fingerprint.